Untreated Menopause Costs the US $26.6 Billion Per Year, Mayo Clinic Finds

The economic cost of not treating menopause is staggering. A study published in Mayo Clinic Proceedings quantified what many women already knew from experience: menopause symptoms have a measurable, significant impact on work performance and healthcare expenditure. The researchers estimated that menopause-related work absences alone cost the US economy $1.8 billion per year. When medical expenses are included, the total annual cost reaches $26.6 billion.

The study surveyed women in the workplace and found that 13.4% reported at least one adverse work outcome directly attributable to menopause symptoms. Among those, 485 women reported missing one or more days of work in the preceding year due to symptoms. And these numbers almost certainly understate the true cost, because they do not capture reduced work hours, job changes, early retirement, or the career trajectory impacts of years spent managing symptoms without adequate support.

The severity of menopause symptoms was the strongest predictor of adverse work outcomes, which means this is not primarily a willpower or coping problem. It is a medical problem with medical solutions. Hormone replacement therapy, when appropriate, can dramatically reduce hot flashes, sleep disruption, mood instability, and cognitive fog. Non-hormonal treatments exist for women who cannot or choose not to use HRT. The bottleneck is not treatment availability; it is the gap between symptom onset and effective clinical intervention.

These findings have direct implications for employers and policymakers. Every dollar invested in menopause support, whether through workplace accommodations, insurance coverage, or clinical access, has a measurable return in retained productivity and reduced healthcare costs.

The Tracking Connection

Kairos™ helps close the gap between symptom onset and treatment by giving women the tools to identify, document, and communicate their symptoms before they reach the point of work disruption. By tracking symptom severity, treatment response, and functional impact over time, Kairos provides the data that both clinicians and employers need to justify and deliver timely support. Early intervention is the most cost-effective intervention, and early intervention requires early detection.